We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$2.09B
AUM Growth
+$76.9M
Cap. Flow
+$113M
Cap. Flow %
5.39%
Top 10 Hldgs %
44.54%
Holding
114
New
28
Increased
33
Reduced
17
Closed
24

Top Buys

Rank Stock Value
1
INSM icon
Insmed
INSM
+$38.4M
2
RVMD icon
Revolution Medicines
RVMD
+$30.3M
3
ROIV icon
Roivant Sciences
ROIV
+$29.5M
4
BSX icon
Boston Scientific
BSX
+$26M
5
MRK icon
Merck
MRK
+$20.2M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$64.8M
2
ISRG icon
Intuitive Surgical
ISRG
+$37.9M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$31.2M
4
PEN icon
Penumbra
PEN
+$31.1M
5
TFX icon
Teleflex
TFX
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 90.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
1
Insmed
INSM
$29.4B
$245M 11.73%
1,500,000
+250,000
+20% +$38.4M
RVMD icon
2
Revolution Medicines
RVMD
$44.4B
$146M 6.98%
1,500,000
+300,000
+25% +$30.3M
CYTK icon
3
Cytokinetics
CYTK
$10.5B
$105M 5.04%
1,600,000
+200,000
+14% +$12.7M
RVMD icon
4
PUT
Revolution Medicines
RVMD
$44.4B
$72.9M 3.49%
+750,000
New +$75.7M
CYTK icon
5
CALL
Cytokinetics
CYTK
$10.5B
$65.9M 3.15%
1,000,000
+500,000
+100% +$31.8M
REGN icon
6
Regeneron Pharmaceuticals
REGN
$83.2B
$65.7M 3.14%
85,000
-20,000
-19% -$15.3M
VERA icon
7
Vera Therapeutics
VERA
$2.27B
$64.4M 3.08%
1,600,000
-200,000
-11% -$8.62M
CAH icon
8
Cardinal Health
CAH
$55.5B
$57.1M 2.73%
270,000
+70,000
+35% +$15.1M
ROIV icon
9
Roivant Sciences
ROIV
$25.8B
$55.4M 2.65%
2,000,000
+1,150,000
+135% +$29.5M
BTSG icon
10
BrightSpring Health Services
BTSG
$12.2B
$53.3M 2.55%
1,250,000
+500,000
+67% +$20.1M
RYTM icon
11
Rhythm Pharmaceuticals
RYTM
$7.95B
$52.2M 2.5%
600,000
+125,000
+26% +$12.2M
MRK icon
12
Merck
MRK
$323B
$51.1M 2.45%
425,000
+175,000
+70% +$20.2M
EWTX icon
13
Edgewise Therapeutics
EWTX
$4.84B
$50.4M 2.41%
1,600,000
+100,000
+7% +$2.88M
AZN icon
14
AstraZeneca
AZN
$251B
$49.3M 2.36%
250,000
+75,000
+43% +$14.5M
RVMD icon
15
CALL
Revolution Medicines
RVMD
$44.4B
$48.6M 2.33%
+500,000
New +$50.5M
ALHC icon
16
Alignment Healthcare
ALHC
$2.86B
$45.4M 2.17%
2,575,000
+375,000
+17% +$7.53M
NVS icon
17
Novartis
NVS
$298B
$38.2M 1.83%
250,000
– –
BSX icon
18
Boston Scientific
BSX
$73.1B
$34.5M 1.65%
550,000
+325,000
+144% +$26M
LFST icon
19
Lifestance Health
LFST
$4.55B
$27.4M 1.31%
4,300,000
+1,300,000
+43% +$9.05M
ASND icon
20
Ascendis Pharma A/S
ASND
$16.8B
$26.3M 1.26%
115,000
+25,000
+28% +$5.6M
SRRK icon
21
Scholar Rock
SRRK
$6.32B
$24.6M 1.18%
500,000
+200,000
+67% +$8.96M
ELV icon
22
Elevance Health
ELV
$86.2B
$22M 1.05%
75,000
+15,000
+25% +$4.93M
CNC icon
23
Centene
CNC
$32.9B
$21.3M 1.02%
650,000
– –
BBIO icon
24
BridgeBio Pharma
BBIO
$16.6B
$20.4M 0.98%
+275,000
New +$19.9M
MLYS icon
25
Mineralys Therapeutics
MLYS
$2.41B
$20.3M 0.97%
750,000
– –
1
2 3 4 5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Integral Health Asset Management held 114 positions worth $2.09B, up 3.8% from $2.01B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Integral Health Asset Management deployed $113M of net new capital in Q1 2026, opening 28 new positions and adding to 33 existing holdings. Its largest new stake was Alumis Inc: 800,000 shares worth $17.6M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 98% a quarter earlier.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $37.9M trimmed.

  • Integral Health Asset Management's largest Q1 2026 buy was Alumis Inc: 800,000 shares worth $17.6M.
  • Integral Health Asset Management added most to Insmed in Q1 2026, an estimated $38.4M increase.
  • Integral Health Asset Management's biggest Q1 2026 reduction was Intuitive Surgical, cutting an estimated $37.9M.
  • Integral Health Asset Management fully exited Medtronic in Q1 2026, selling an estimated $64.8M.
  • Integral Health Asset Management's ten largest holdings make up 45% of its $2.09B portfolio in Q1 2026.
  • Integral Health Asset Management opened 28 new positions and closed 24 in Q1 2026.
  • Integral Health Asset Management's portfolio value rose 3.8% quarter-over-quarter to $2.09B.

Based on Integral Health Asset Management's 13F filing for Q1 2026, filed 15 May 2026.